Notes
funded by Gilead Sciences
Reference
Connolly M, et al. Estimating the Public Economic Impact of Different Hepatitis C Healthcare Policies in the Netherlands. 20th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research : (plus oral presentation) abstr. IN1, 4 Nov 2017. Available from: URL: https://www.ispor.org/ScientificPresentationsDatabase/Presentation/76121?pdfid=52284
Rights and permissions
About this article
Cite this article
Early treatment of HCV dominates treatment at later stage. PharmacoEcon Outcomes News 793, 15 (2017). https://doi.org/10.1007/s40274-017-4575-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-017-4575-6